Geopolitics Alpha

Aprea Therapeutics (APRE): filings, insider buys & geopolitical news

In the last 30 days, Geopolitics Alpha logged 1 item on Aprea Therapeutics: 0 news stories, 1 SEC filing and 0 fund or insider trade reports. The latest filing was logged 04 Nov 2026: 8-K - Aprea Therapeutics, Inc. (0001781983) (Filer).

Government contracts

No federal prime contract obligations are matched to Aprea Therapeutics in USAspending.gov for the last five years, and no Department of Defense contract announcements name it in the past year. See the largest government contractors.

APRE share price, last 12 months

Close $0.75 on Sep 15, 2026, -46.4% since Oct 31, 2025 (range $0.59 to $1.40, daily closes).

What changed for Aprea Therapeutics (APRE)

In the last 30 days, Geopolitics Alpha logged 1 item on Aprea Therapeutics: 0 news stories, 1 SEC filing and 0 fund or insider trade reports. The latest filing was logged 04 Nov 2026: 8-K - Aprea Therapeutics, Inc. (0001781983) (Filer).

Latest SEC filings

Latest fund & insider buys and sales

None on record yet.

Latest geopolitical & market news

None on record yet.

Congressional trades in APRE

Trades in APRE that members of Congress have publicly reported, newest filing first.

No congressional trades are stored for this view yet.

All congressional stock trades →

Geopolitical news for APRE

Everything on APRE, newest first

Frequently asked questions

Does Aprea Therapeutics have government contracts?

No federal prime contract obligations are matched to Aprea Therapeutics (APRE) in USAspending.gov for the last five years. Subcontracts are not included.

Where does the contract data come from?

USAspending.gov (the official source of U.S. federal spending data) and the Department of Defense's daily contract announcements. Both are public domain and refreshed daily here.

What geopolitical news affects APRE?

This page lists every Geopolitics Alpha note that names APRE as exposed to an event, with the reason it is exposed.

Has Congress traded APRE?

The table above lists trades in APRE that members of Congress have publicly reported, with a link to each official filing.

Is this investment advice?

No. We show news, exposure and past price moves. Nothing here is a recommendation.